Open labeled, active controlled, randomized evaluation of adjuvent effect of Dhatrinisha Vati in Madhumeha vis- a- vis Diabetes Mellitus type- II

Maharashtra Arogya Mandals Sumatibhai Shah Ayurved Mahavidyalaya0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. A known diabetic on treatment and a newly diagnosed diabetic.
•2. Patients presenting classical symptoms of Madhumeha.
•3. Patient with fasting blood sugar up to 220 mg% and post prandial blood sugar up to 300 mg%.
•4. Patient showing good, fair and moderate control in HbA1c test.
•5. Patients having fasting blood sugar in between 221 to 250 and post prandial 301 to 400 and if they are having good, fair, moderate control in HbA1C and normal fundoscopy.

•1.Patients with fasting blood sugar above 220 mg% and post prandial blood sugar above 300mg%.
•2.Diabetes Mellitus Type-I and those who are under insulin therapy.
•3.Pregnant and lactating mothers, known cases of Gestational Diabetes.
•4.Patients with acute complications like Hyperglycemic coma, Ketoacidosis, and infections like gangrene.
•5.Patients with chronic complications like Nephropathy, Neuropathy and Retinopathy.
•6.Patients suffering from other diseases such as Tuberculosis, Cardiac diseases, HIV.

发起方

Maharashtra Arogya Mandals Sumatibhai Shah Ayurved Mahavidyalaya